HAMILTON THORNE LTD. Hamilton Thorne Ltd. Share Price Deutsche Boerse AG
Equities
0ZM
CA4078911001
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.96 EUR | +1.05% |
|
+2.67% | +0.52% |
| 14/05 | Hamilton Thorne Q1 Loss Widens Even as Sales Increase | MT |
| 14/05 | Transcript : Hamilton Thorne Ltd., Q1 2024 Earnings Call, May 14, 2024 |
| Sales 2024 * | 7.96Cr 7.44Cr 664.85Cr | Sales 2025 * | 8.72Cr 8.15Cr 727.99Cr | Capitalization | 16Cr 15Cr 1.36TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 20L 18.7L 17Cr | Net income 2025 * | 50L 46.76L 42Cr | EV / Sales 2024 * | 2.14 x |
| Net Debt 2024 * | 74L 69.21L 62Cr | Net cash position 2025 * | 31L 28.99L 26Cr | EV / Sales 2025 * | 1.84 x |
| P/E ratio 2024 * |
63.7
x | P/E ratio 2025 * |
30.3
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.66% |
More Fundamentals
* Assessed data
More news
Latest transcript on Hamilton Thorne Ltd.
More press releases
| 1 day | +1.05% | ||
| 1 week | +2.67% | ||
| Current month | +4.35% | ||
| 1 month | +7.26% | ||
| 3 months | +10.98% | ||
| 6 months | +13.61% | ||
| Current year | +0.52% |
1 week
0.94
1.00
1 month
0.901.00
Current year
0.841.02
1 year
0.741.07
3 years
0.741.51
5 years
0.591.51
10 years
0.441.51
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 15/01 | |
David Wolf
CHM | Chairman | - | 01/11/01 |
| Director of Finance/CFO | - | 01/22/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Thorne
BRD | Director/Board Member | - | 28/09/28 |
| Chief Executive Officer | - | 15/01 | |
Kari Firestone
BRD | Director/Board Member | 68 | 18/22/18 |
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 0.96 | +1.05% |
| 13/24/13 | 0.95 | -0.52% |
| 12/24/12 | 0.955 | -0.52% |
| 11/24/11 | 0.96 | -3.52% |
| 10/24/10 | 0.995 | +6.42% |
Delayed Quote Deutsche Boerse AG, June 14, 2024 at 11:35 am IST
More quotes
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Calendar
21/08/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
1.062
USD
Average target price
1.666
USD
Spread / Average Target
+56.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.88% | 22TCr | |
| +10.23% | 19TCr | |
| +25.36% | 15TCr | |
| +33.13% | 11TCr | |
| +2.24% | 6.5TCr | |
| +14.98% | 5.28TCr | |
| +1.91% | 4.94TCr | |
| -6.09% | 3.81TCr | |
| -0.43% | 3.51TCr |
- Stock Market
- Equities
- HTL Stock
- 0ZM Stock
